Annual Operating Expenses
$4.53 M
+$969.20 K+27.24%
December 31, 2023
Summary
- As of February 7, 2025, PTIX annual total operating expenses is $4.53 million, with the most recent change of +$969.20 thousand (+27.24%) on December 31, 2023.
- During the last 3 years, PTIX annual operating expenses has risen by +$1.98 million (+77.42%).
- PTIX annual operating expenses is now -87.92% below its all-time high of $37.47 million, reached on December 31, 2007.
Performance
PTIX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$652.10 K
-$1.02 M-60.89%
September 30, 2024
Summary
- As of February 7, 2025, PTIX quarterly total operating expenses is $652.10 thousand, with the most recent change of -$1.02 million (-60.89%) on September 30, 2024.
- Over the past year, PTIX quarterly operating expenses has dropped by -$1.02 million (-60.89%).
- PTIX quarterly operating expenses is now -95.54% below its all-time high of $14.64 million, reached on March 31, 2008.
Performance
PTIX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PTIX Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +27.2% | -60.9% |
3 y3 years | +77.4% | -60.9% |
5 y5 years | +95.6% | -60.9% |
PTIX Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +27.2% | -62.5% | +2.4% |
5 y | 5-year | at high | +117.0% | -62.5% | +33.4% |
alltime | all time | -87.9% | -100.0% | -95.5% | +106.6% |
Protagenic Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $652.10 K(-60.9%) |
Jun 2024 | - | $1.67 M(-4.1%) |
Mar 2024 | - | $1.74 M(+43.4%) |
Dec 2023 | $4.53 M(+27.2%) | $1.21 M(-15.3%) |
Sep 2023 | - | $1.43 M(+25.2%) |
Jun 2023 | - | $1.14 M(+54.7%) |
Mar 2023 | - | $739.30 K(+12.7%) |
Dec 2022 | $3.56 M(-14.1%) | $655.80 K(-29.0%) |
Sep 2022 | - | $924.10 K(+45.1%) |
Jun 2022 | - | $636.70 K(-52.5%) |
Mar 2022 | - | $1.34 M(+55.7%) |
Dec 2021 | $4.14 M(+62.3%) | $861.20 K(+12.7%) |
Sep 2021 | - | $764.20 K(-41.6%) |
Jun 2021 | - | $1.31 M(+8.5%) |
Mar 2021 | - | $1.21 M(+124.7%) |
Dec 2020 | $2.55 M(+22.3%) | $536.90 K(-50.8%) |
Sep 2020 | - | $1.09 M(+123.4%) |
Jun 2020 | - | $488.90 K(-6.1%) |
Mar 2020 | - | $520.70 K(-29.4%) |
Dec 2019 | $2.09 M(-9.9%) | $737.20 K(+288.8%) |
Sep 2019 | - | $189.60 K(-62.5%) |
Jun 2019 | - | $505.30 K(-22.7%) |
Mar 2019 | - | $654.00 K(+24.8%) |
Dec 2018 | $2.31 M(-2.2%) | $524.20 K(+5.2%) |
Sep 2018 | - | $498.10 K(-27.3%) |
Jun 2018 | - | $685.10 K(+12.9%) |
Mar 2018 | - | $606.70 K(-14.4%) |
Dec 2017 | $2.37 M(+29.3%) | $708.80 K(+34.5%) |
Sep 2017 | - | $527.00 K(+11.7%) |
Jun 2017 | - | $471.60 K(-28.3%) |
Mar 2017 | - | $657.90 K(+18.3%) |
Dec 2016 | $1.83 M(+272.6%) | $556.30 K(+22.3%) |
Sep 2016 | - | $454.80 K(-8.4%) |
Jun 2016 | - | $496.70 K(+54.4%) |
Mar 2016 | - | $321.60 K(+113.0%) |
Dec 2015 | - | $151.00 K(+16.2%) |
Sep 2015 | - | $130.00 K(+14.0%) |
Jun 2015 | $491.00 K(-49.6%) | $114.00 K(-5.8%) |
Mar 2015 | - | $121.00 K(-11.7%) |
Dec 2014 | - | $137.00 K(+16.1%) |
Sep 2014 | - | $118.00 K(-9.2%) |
Jun 2014 | $975.00 K(+28.6%) | $130.00 K(-67.3%) |
Mar 2014 | - | $398.00 K(+64.5%) |
Dec 2013 | - | $242.00 K(+17.5%) |
Sep 2013 | - | $206.00 K(-92.9%) |
Jun 2013 | $758.00 K(-94.9%) | - |
Sep 2011 | - | $2.92 M(-9.5%) |
Jun 2011 | - | $3.23 M(+10.7%) |
Mar 2011 | - | $2.91 M(-3.8%) |
Dec 2010 | $14.77 M | $3.03 M(-21.5%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2010 | - | $3.86 M(-7.3%) |
Jun 2010 | - | $4.16 M(+12.1%) |
Mar 2010 | - | $3.71 M(-38.3%) |
Dec 2009 | $26.79 M(-16.0%) | $6.02 M(-5.6%) |
Sep 2009 | - | $6.38 M(-6.1%) |
Jun 2009 | - | $6.79 M(-10.8%) |
Mar 2009 | - | $7.61 M(-283.4%) |
Dec 2008 | $31.90 M(-14.9%) | -$4.15 M(-142.1%) |
Sep 2008 | - | $9.85 M(-13.1%) |
Jun 2008 | - | $11.32 M(-22.6%) |
Mar 2008 | - | $14.64 M(+6.7%) |
Dec 2007 | $37.47 M(+125.0%) | $13.71 M(+22.3%) |
Sep 2007 | - | $11.21 M(+52.3%) |
Jun 2007 | - | $7.36 M(+41.9%) |
Mar 2007 | - | $5.19 M(>+9900.0%) |
Dec 2006 | $16.65 M(>+9900.0%) | - |
Oct 2006 | - | $14.40 K(-100.1%) |
Jul 2006 | - | -$9.86 M(-285.1%) |
Jul 2006 | $71.00 K(-24.9%) | - |
Apr 2006 | - | $5.33 M(>+9900.0%) |
Jan 2006 | - | $9700.00(-80.8%) |
Oct 2005 | - | $50.40 K(-97.1%) |
Jul 2005 | $94.50 K(>+9900.0%) | - |
Jul 2004 | $0.00(-100.0%) | - |
Apr 2003 | - | $1.75 M(+8.8%) |
Jan 2003 | - | $1.61 M(-9.4%) |
Oct 2002 | - | $1.77 M(-21.3%) |
Jul 2002 | $8.55 M(-0.7%) | $2.25 M(+3.5%) |
Apr 2002 | - | $2.18 M(+2.1%) |
Jan 2002 | - | $2.13 M(+7.0%) |
Oct 2001 | - | $1.99 M(-14.2%) |
Jul 2001 | $8.61 M(+10.8%) | $2.32 M(+8.5%) |
Apr 2001 | - | $2.14 M(-3.9%) |
Jan 2001 | - | $2.23 M(+15.7%) |
Oct 2000 | - | $1.92 M(+284.0%) |
Jul 2000 | $7.77 M(-3.8%) | $501.00 K(-80.4%) |
Apr 2000 | - | $2.56 M(+6.5%) |
Jan 2000 | - | $2.40 M(0.0%) |
Oct 1999 | - | $2.40 M(+313.8%) |
Jul 1999 | $8.08 M(+16.3%) | $580.00 K(-78.5%) |
Apr 1999 | - | $2.70 M(+12.5%) |
Jan 1999 | - | $2.40 M(0.0%) |
Oct 1998 | - | $2.40 M(+270.9%) |
Jul 1998 | $6.95 M(-8.6%) | $647.00 K(-73.0%) |
Apr 1998 | - | $2.40 M(+20.0%) |
Jan 1998 | - | $2.00 M(0.0%) |
Oct 1997 | - | $2.00 M(+17.6%) |
Jul 1997 | $7.60 M | $1.70 M(-10.5%) |
Apr 1997 | - | $1.90 M(-9.5%) |
Jan 1997 | - | $2.10 M |
FAQ
- What is Protagenic Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Protagenic Therapeutics?
- What is Protagenic Therapeutics annual operating expenses year-on-year change?
- What is Protagenic Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Protagenic Therapeutics?
- What is Protagenic Therapeutics quarterly operating expenses year-on-year change?
What is Protagenic Therapeutics annual total operating expenses?
The current annual operating expenses of PTIX is $4.53 M
What is the all time high annual operating expenses for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual total operating expenses is $37.47 M
What is Protagenic Therapeutics annual operating expenses year-on-year change?
Over the past year, PTIX annual total operating expenses has changed by +$969.20 K (+27.24%)
What is Protagenic Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of PTIX is $652.10 K
What is the all time high quarterly operating expenses for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly total operating expenses is $14.64 M
What is Protagenic Therapeutics quarterly operating expenses year-on-year change?
Over the past year, PTIX quarterly total operating expenses has changed by -$1.02 M (-60.89%)